JULY 2010
CONGRESS STILL STALLED ON RESEARCH APPROPRIATIONS
November elections overshadow work on Capitol Hill
Congress returns from the Fourth of July recess this week with a full schedule before legislators pack up again for an extended August recess. Read more
OP-ED: FINDING MY VOICE AND MAKING A DIFFERENCE
By Aime T. Franco, Ph.D.
Eleven years ago I was diagnosed with thyroid cancer. I am fortunate that the cancer was caught early and that I have been cancer-free for 10 years, but that experience will always stay with me. It solidified my career choice as a cancer researcher and strengthened my resolve to do everything I could to make sure others would not have to hear those words, "yes, it is cancer." Read more
REPORT RELEASED BY AACR-FDA-NCI CANCER BIOMARKERS COLLABORATIVE
Report identifies areas for biomarker development & strategies to accelerate cancer therapies to patients
The rate at which biomarkers are discovered far outpaces the rate at which that information is translated to patient benefit. This challenge has been a primary focus of the Cancer Biomarkers Collaborative (CBC), a stakeholder-driven effort established by the AACR, in partnership with FDA and NCI. Read more
COLLINS ADDRESSES SKEPTICISM ABOUT HUMAN GENOME
Underscores transformational impact on study and treatment of cancer
Ten years after the completion of the first draft of the human genome, the public and media are looking for evidence of its impact on treating disease and wondering whether the large-scale project was worth the financial investment. Read more
CONGRESSIONAL PANEL HEARS NIH DIRECTOR’S VISION FOR RESEARCH
Collins boasts "striking" progress against cancer and other diseases
NIH Chief, Dr. Francis Collins, took to Capitol Hill last month to tout the pace of innovation and value of scientific discovery fueled by the NIH. Read more
NATIONAL CANCER ADVISORY BOARD EVALUATES NCI ACTIVITIES
Panel examines clinical trials, drug development and electronic health records
The National Cancer Advisory Board (NCAB) recently convened for two days on the NIH campus to evaluate the direction of the national cancer program. Read more
Top
JUNE 20Top10